Symbols / MEDP
MEDP Chart
About
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Diagnostics & Research | Market Cap | 12.82B |
| Enterprise Value | 12.46B | Income | 451.12M | Sales | 2.53B |
| Book/sh | 16.18 | Cash/sh | 17.51 | Dividend Yield | — |
| Payout | 0.00% | Employees | 6200 | IPO | — |
| P/E | 29.58 | Forward P/E | 23.54 | PEG | — |
| P/S | 5.07 | P/B | 27.92 | P/C | — |
| EV/EBITDA | 22.13 | EV/Sales | 4.92 | Quick Ratio | 0.69 |
| Current Ratio | 0.74 | Debt/Eq | 29.81 | LT Debt/Eq | — |
| EPS (ttm) | 15.27 | EPS next Y | 19.19 | EPS Growth | 26.90% |
| Revenue Growth | 32.00% | Earnings | 2026-04-20 | ROA | 16.40% |
| ROE | 70.23% | ROIC | — | Gross Margin | 71.06% |
| Oper. Margin | 21.63% | Profit Margin | 17.83% | Shs Outstand | 28.38M |
| Shs Float | 22.84M | Short Float | 5.73% | Short Ratio | 3.37 |
| Short Interest | — | 52W High | 628.92 | 52W Low | 250.05 |
| Beta | 1.40 | Avg Volume | 315.80K | Volume | 383.41K |
| Target Price | $486.92 | Recom | Hold | Prev Close | $447.09 |
| Price | $451.76 | Change | 1.04% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$486.92
Mean price target
2. Current target
$451.76
Latest analyst target
3. DCF / Fair value
$299.59
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$451.76
Low
$329.00
High
$582.00
Mean
$486.92
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-02-18 | up | TD Cowen | Sell → Hold | $419 |
| 2026-02-13 | up | Jefferies | Hold → Buy | $560 |
| 2026-02-11 | main | Barclays | Underweight → Underweight | $500 |
| 2026-02-11 | main | Truist Securities | Hold → Hold | $539 |
| 2026-02-11 | main | Leerink Partners | Market Perform → Market Perform | $485 |
| 2025-12-15 | main | Barclays | Underweight → Underweight | $525 |
| 2025-11-13 | init | BMO Capital | — → Market Perform | $600 |
| 2025-10-27 | main | Truist Securities | Hold → Hold | $555 |
| 2025-10-24 | main | TD Cowen | Sell → Sell | $462 |
| 2025-10-24 | main | Barclays | Underweight → Underweight | $485 |
| 2025-10-24 | main | Mizuho | Outperform → Outperform | $655 |
| 2025-10-17 | main | Mizuho | Outperform → Outperform | $575 |
| 2025-10-02 | down | Barclays | Equal-Weight → Underweight | $425 |
| 2025-09-09 | main | Jefferies | Hold → Hold | $450 |
| 2025-09-03 | down | Rothschild & Co | Buy → Neutral | $474 |
| 2025-07-29 | down | UBS | Neutral → Sell | $305 |
| 2025-07-25 | main | Mizuho | Outperform → Outperform | $510 |
| 2025-07-23 | main | Truist Securities | Hold → Hold | $436 |
| 2025-07-23 | main | Deutsche Bank | Hold → Hold | $430 |
| 2025-07-23 | main | Barclays | Equal-Weight → Equal-Weight | $450 |
- Medpace Holdings, Inc. $MEDP Shares Sold by Findlay Park Partners LLP - MarketBeat Sat, 28 Feb 2026 12
- MEDP Stock News Today | Earnings, Events & Price Alerts - Intellectia AI Sat, 28 Feb 2026 05
- The 'Key Negative' That Took Out Medpace's Sales, Profit Beat - Investor's Business Daily ue, 10 Feb 2026 08
- Evaluating Medpace Holdings (MEDP) After A Sharp 27% One-Month Pullback - Yahoo Finance Wed, 25 Feb 2026 23
- Is It Time To Reassess Medpace Holdings (MEDP) After The Recent Share Price Pullback - simplywall.st Wed, 25 Feb 2026 08
- Medpace Holdings Under Investigation After Book-to-Bill Miss Exposes Cancellation Surge and Pipeline Fragility - PR Newswire Wed, 18 Feb 2026 14
- Medpace Holdings Inc. (MEDP) Stock Falls on Q4 2025 Earnings - Quiver Quantitative Mon, 09 Feb 2026 08
- (MEDP) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily hu, 26 Feb 2026 02
- Medpace Holdings, Inc. $MEDP Stock Holdings Lowered by TD Asset Management Inc - MarketBeat Fri, 27 Feb 2026 10
- Medpace 2025 revenue tops $2.5B after 20% jump, plans more growth in 2026 - Stock Titan Mon, 09 Feb 2026 08
- MEDP: Today's Analyst Rating by TD Cowen | MEDP Stock News - GuruFocus Wed, 18 Feb 2026 19
- Medpace Holdings (MEDP) price target decreased by 10.76% to 497.46 - MSN Wed, 25 Feb 2026 19
- Medpace (MEDP) Rises As Market Takes a Dip: Key Facts - Yahoo Finance hu, 26 Feb 2026 23
- $MEDP stock is down 10% today. Here's what we see in our data. - Quiver Quantitative ue, 10 Feb 2026 08
- Quantbot Technologies LP Has $8.34 Million Position in Medpace Holdings, Inc. $MEDP - MarketBeat Sat, 28 Feb 2026 12
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 3500 | 486045.0 | — | Conversion of Exercise of derivative security at price 138.87 per share. | EWALD STEPHEN P | General Counsel | — | 2026-02-17 00:00:00 | D |
| 1 | 10984 | 1185503.0 | — | Conversion of Exercise of derivative security at price 107.93 per share. | BURWIG SUSAN ELIZABETH | Officer | — | 2026-02-13 00:00:00 | D |
| 2 | 6472 | 355895.0 | — | Conversion of Exercise of derivative security at price 54.99 per share. | CARLEY BRIAN T | Director | — | 2026-02-13 00:00:00 | D |
| 3 | 56 | nan | — | — | KRAFT ROBERT O | Director | — | 2025-12-31 00:00:00 | D |
| 4 | 62 | nan | — | — | CARLEY BRIAN T | Director | — | 2025-12-31 00:00:00 | D |
| 5 | 49 | nan | — | — | MCCARTHY CORNELIUS P. III | Director | — | 2025-12-31 00:00:00 | D |
| 6 | 10000 | 1079300.0 | — | Conversion of Exercise of derivative security at price 107.93 per share. | BURWIG SUSAN ELIZABETH | Officer | — | 2025-12-05 00:00:00 | D |
| 7 | 668 | 394581.0 | — | Sale at price 590.69 per share. | TROENDLE AUGUST J | Chief Executive Officer | — | 2025-12-03 00:00:00 | D |
| 8 | 28876 | 17114847.0 | — | Sale at price 590.47 - 593.25 per share. | TROENDLE AUGUST J | Chief Executive Officer | — | 2025-12-02 00:00:00 | D |
| 9 | 10000 | 1079300.0 | — | Conversion of Exercise of derivative security at price 107.93 per share. | BURWIG SUSAN ELIZABETH | Officer | — | 2025-12-02 00:00:00 | D |
Financials
| Line Item | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | -1.30M | -74.40K | -304.78K | 513.25K |
| TaxRateForCalcs | 0.17 | 0.15 | 0.16 | 0.13 |
| NormalizedEBITDA | 570.79M | 476.62M | 365.08M | 297.18M |
| TotalUnusualItems | -7.73M | -496.00K | -1.93M | 3.86M |
| TotalUnusualItemsExcludingGoodwill | -7.73M | -496.00K | -1.93M | 3.86M |
| NetIncomeFromContinuingOperationNetMinorityInterest | 451.12M | 404.39M | 282.81M | 245.37M |
| ReconciledDepreciation | 28.12M | 29.25M | 26.33M | 22.34M |
| ReconciledCostOfRevenue | 1.77B | 1.45B | 1.36B | 1.03B |
| EBITDA | 563.06M | 476.12M | 363.15M | 301.04M |
| EBIT | 534.93M | 446.87M | 336.82M | 278.70M |
| NetInterestIncome | 12.78M | 25.00M | -488.00K | -2.90M |
| NormalizedIncome | 457.56M | 404.81M | 284.43M | 242.02M |
| NetIncomeFromContinuingAndDiscontinuedOperation | 451.12M | 404.39M | 282.81M | 245.37M |
| TotalExpenses | 2.00B | 1.66B | 1.55B | 1.18B |
| TotalOperatingIncomeAsReported | 534.93M | 446.87M | 336.82M | 278.70M |
| DilutedAverageShares | 32.01M | 31.84M | 33.67M | 37.70M |
| BasicAverageShares | 30.96M | 30.72M | 32.39M | 35.86M |
| DilutedEPS | 12.63 | 8.88 | 7.28 | 4.81 |
| BasicEPS | 13.06 | 9.20 | 7.57 | 5.06 |
| DilutedNIAvailtoComStockholders | 451.12M | 404.34M | 282.62M | 245.21M |
| NetIncomeCommonStockholders | 451.12M | 404.34M | 282.62M | 245.21M |
| OtherunderPreferredStockDividend | 0.00 | 44.00K | 191.00K | 157.00K |
| NetIncome | 451.12M | 404.39M | 282.81M | 245.37M |
| NetIncomeIncludingNoncontrollingInterests | 451.12M | 404.39M | 282.81M | 245.37M |
| NetIncomeContinuousOperations | 451.12M | 404.39M | 282.81M | 245.37M |
| TaxProvision | 91.25M | 71.54M | 52.87M | 37.49M |
| PretaxIncome | 542.38M | 475.92M | 335.68M | 282.86M |
| OtherIncomeExpense | -5.34M | 4.06M | -655.00K | 7.07M |
| OtherNonOperatingIncomeExpenses | 2.39M | 4.55M | 1.27M | 3.21M |
| GainOnSaleOfSecurity | -7.73M | -496.00K | -1.93M | 3.86M |
| NetNonOperatingInterestIncomeExpense | 12.78M | 25.00M | -488.00K | -2.90M |
| TotalOtherFinanceCost | -12.78M | -25.00M | 488.00K | 2.90M |
| OperatingIncome | 534.93M | 446.87M | 336.82M | 278.70M |
| OperatingExpense | 225.68M | 209.44M | 187.68M | 153.74M |
| DepreciationAmortizationDepletionIncomeStatement | 28.12M | 29.25M | 26.33M | 22.34M |
| DepreciationAndAmortizationInIncomeStatement | 28.12M | 29.25M | 26.33M | 22.34M |
| Amortization | 946.00K | 1.44M | 2.20M | 3.35M |
| AmortizationOfIntangiblesIncomeStatement | 946.00K | 1.44M | 2.20M | 3.35M |
| DepreciationIncomeStatement | 27.18M | 27.81M | 24.13M | 18.99M |
| SellingGeneralAndAdministration | 197.56M | 180.18M | 161.35M | 131.40M |
| GrossProfit | 760.62M | 656.30M | 524.50M | 432.44M |
| CostOfRevenue | 1.77B | 1.45B | 1.36B | 1.03B |
| TotalRevenue | 2.53B | 2.11B | 1.89B | 1.46B |
| OperatingRevenue | 2.53B | 2.11B | 1.89B | 1.46B |
| Line Item | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| TreasurySharesNumber | 69.62K | 70.07K | 70.57K | 71.57K |
| OrdinarySharesNumber | 28.37M | 30.63M | 30.75M | 31.09M |
| ShareIssued | 28.44M | 30.70M | 30.82M | 31.16M |
| NetDebt | 21.73M | |||
| TotalDebt | 113.64M | 126.23M | 142.12M | 188.87M |
| TangibleBookValue | -236.75M | 128.78M | -139.25M | -314.02M |
| InvestedCapital | 459.07M | 825.54M | 558.95M | 436.39M |
| WorkingCapital | -354.12M | -75.32M | -331.30M | -469.51M |
| NetTangibleAssets | -236.75M | 128.78M | -139.25M | -314.02M |
| CapitalLeaseObligations | 113.64M | 126.23M | 142.12M | 138.87M |
| CommonStockEquity | 459.07M | 825.54M | 558.95M | 386.39M |
| TotalCapitalization | 459.07M | 825.54M | 558.95M | 386.39M |
| TotalEquityGrossMinorityInterest | 459.07M | 825.54M | 558.95M | 386.39M |
| StockholdersEquity | 459.07M | 825.54M | 558.95M | 386.39M |
| GainsLossesNotAffectingRetainedEarnings | -4.91M | -14.74M | -10.07M | -12.39M |
| OtherEquityAdjustments | -4.91M | -14.74M | -10.07M | -12.39M |
| TreasuryStock | 12.16M | 12.23M | 12.32M | 12.50M |
| RetainedEarnings | -459.98M | 8.17M | -221.65M | -359.83M |
| AdditionalPaidInCapital | 935.83M | 844.05M | 802.68M | 770.79M |
| CapitalStock | 284.00K | 306.00K | 308.00K | 309.00K |
| CommonStock | 284.00K | 306.00K | 308.00K | 309.00K |
| PreferredStock | 0.00 | 0.00 | 0.00 | 0.00 |
| TotalLiabilitiesNetMinorityInterest | 1.52B | 1.28B | 1.10B | 966.11M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 172.65M | 170.77M | 172.75M | 162.64M |
| OtherNonCurrentLiabilities | 57.66M | 42.73M | 28.22M | 22.70M |
| NonCurrentDeferredLiabilities | 1.35M | 1.80M | 2.40M | 1.07M |
| NonCurrentDeferredTaxesLiabilities | 1.35M | 1.80M | 2.40M | 1.07M |
| LongTermDebtAndCapitalLeaseObligation | 113.64M | 126.23M | 142.12M | 138.87M |
| LongTermCapitalLeaseObligation | 113.64M | 126.23M | 142.12M | 138.87M |
| CurrentLiabilities | 1.34B | 1.10B | 925.13M | 803.47M |
| OtherCurrentLiabilities | 52.83M | 53.63M | 40.44M | 47.55M |
| CurrentDeferredLiabilities | 854.39M | 710.59M | 559.86M | 462.73M |
| CurrentDeferredRevenue | 854.39M | 710.59M | 559.86M | 462.73M |
| CurrentDebtAndCapitalLeaseObligation | 50.00M | |||
| CurrentDebt | 50.00M | |||
| LineOfCredit | 0.00 | 50.00M | 0.00 | |
| PensionandOtherPostRetirementBenefitPlansCurrent | 80.14M | 84.93M | 75.82M | 71.20M |
| PayablesAndAccruedExpenses | 356.38M | 255.41M | 249.01M | 172.00M |
| CurrentAccruedExpenses | 328.24M | 222.88M | 217.14M | 138.93M |
| Payables | 28.14M | 32.53M | 31.87M | 33.07M |
| AccountsPayable | 28.14M | 32.53M | 31.87M | 33.07M |
| TotalAssets | 1.98B | 2.10B | 1.66B | 1.35B |
| TotalNonCurrentAssets | 985.85M | 1.07B | 1.06B | 1.02B |
| OtherNonCurrentAssets | 21.94M | 22.25M | 24.97M | 21.13M |
| NonCurrentDeferredAssets | 19.22M | 100.36M | 74.44M | 48.08M |
| NonCurrentDeferredTaxesAssets | 19.22M | 100.36M | 74.44M | 48.08M |
| GoodwillAndOtherIntangibleAssets | 695.82M | 696.76M | 698.21M | 700.40M |
| OtherIntangibleAssets | 33.42M | 34.37M | 35.81M | 38.01M |
| Goodwill | 662.40M | 662.40M | 662.40M | 662.40M |
| NetPPE | 248.87M | 252.26M | 265.39M | 248.92M |
| AccumulatedDepreciation | -123.27M | -98.87M | -79.40M | -62.12M |
| GrossPPE | 372.14M | 351.13M | 344.79M | 311.03M |
| ConstructionInProgress | 12.77M | 21.17M | 7.18M | 10.52M |
| OtherProperties | 171.17M | 174.29M | 184.73M | 170.92M |
| MachineryFurnitureEquipment | 142.61M | 134.83M | 131.63M | 113.59M |
| BuildingsAndImprovements | 40.45M | 15.81M | 16.42M | 13.59M |
| LandAndImprovements | 5.14M | 5.03M | 4.83M | 2.41M |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 989.62M | 1.03B | 593.83M | 333.96M |
| OtherCurrentAssets | 90.50M | 63.35M | 49.98M | 52.29M |
| PrepaidAssets | 43.18M | |||
| Receivables | 402.08M | 296.44M | 298.40M | 253.40M |
| ReceivablesAdjustmentsAllowances | -29.00K | 0.00 | -7.00K | -170.00K |
| OtherReceivables | 25.35M | 5.35M | 22.48M | 40.41M |
| AccountsReceivable | 376.75M | 291.10M | 275.93M | 213.17M |
| CashCashEquivalentsAndShortTermInvestments | 497.05M | 669.44M | 245.45M | 28.27M |
| CashAndCashEquivalents | 497.05M | 669.44M | 245.45M | 28.27M |
| Line Item | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| FreeCashFlow | 681.87M | 572.27M | 396.73M | 351.17M |
| RepurchaseOfCapitalStock | -917.39M | -169.87M | -144.02M | -847.85M |
| RepaymentOfDebt | 0.00 | 0.00 | -155.00M | -274.20M |
| IssuanceOfDebt | 0.00 | 0.00 | 105.00M | 324.20M |
| CapitalExpenditure | -31.36M | -36.55M | -36.65M | -36.88M |
| InterestPaidSupplementalData | 0.00 | 171.00K | 3.06M | 2.94M |
| IncomeTaxPaidSupplementalData | 39.72M | 83.57M | 76.35M | 50.16M |
| EndCashPosition | 497.05M | 669.44M | 245.45M | 28.27M |
| BeginningCashPosition | 669.44M | 245.45M | 28.27M | 461.30M |
| EffectOfExchangeRateChanges | 5.92M | -2.51M | 1.08M | -6.57M |
| ChangesInCash | -178.31M | 426.50M | 216.10M | -426.47M |
| FinancingCashFlow | -860.39M | -154.01M | -182.64M | -775.77M |
| CashFlowFromContinuingFinancingActivities | -860.39M | -154.01M | -182.64M | -775.77M |
| ProceedsFromStockOptionExercised | 57.00M | 15.86M | 11.38M | 22.07M |
| NetCommonStockIssuance | -917.39M | -169.87M | -144.02M | -847.85M |
| CommonStockPayments | -917.39M | -169.87M | -144.02M | -847.85M |
| NetIssuancePaymentsOfDebt | 0.00 | 0.00 | -50.00M | 50.00M |
| NetShortTermDebtIssuance | 0.00 | 0.00 | -50.00M | 50.00M |
| ShortTermDebtPayments | 0.00 | 0.00 | -155.00M | -274.20M |
| ShortTermDebtIssuance | 0.00 | 0.00 | 105.00M | 324.20M |
| NetLongTermDebtIssuance | 0.00 | |||
| LongTermDebtPayments | 0.00 | |||
| InvestingCashFlow | -31.14M | -28.31M | -34.63M | -38.74M |
| CashFlowFromContinuingInvestingActivities | -31.14M | -28.31M | -34.63M | -38.74M |
| NetOtherInvestingChanges | 216.00K | 8.24M | 2.02M | -1.86M |
| NetPPEPurchaseAndSale | -31.36M | -36.55M | -36.65M | -36.88M |
| PurchaseOfPPE | -31.36M | -36.55M | -36.65M | -36.88M |
| CapitalExpenditureReported | -28.27M | |||
| OperatingCashFlow | 713.22M | 608.82M | 433.37M | 388.05M |
| CashFlowFromContinuingOperatingActivities | 713.22M | 608.82M | 433.37M | 388.05M |
| ChangeInWorkingCapital | 96.28M | 157.18M | 106.49M | 106.06M |
| ChangeInOtherWorkingCapital | 155.04M | 174.52M | 87.52M | 140.14M |
| ChangeInOtherCurrentLiabilities | -25.16M | -21.41M | -18.87M | -15.90M |
| ChangeInPayablesAndAccruedExpense | 99.71M | 13.92M | 83.13M | 58.91M |
| ChangeInAccruedExpense | 97.08M | 16.88M | 82.08M | 52.48M |
| ChangeInPayable | 2.63M | -2.96M | 1.05M | 6.43M |
| ChangeInAccountPayable | 2.63M | -2.96M | 1.05M | 6.43M |
| ChangeInPrepaidAssets | -27.10M | -12.09M | 2.99M | -10.18M |
| ChangeInReceivables | -106.22M | 2.24M | -48.28M | -66.92M |
| OtherNonCashItems | 22.14M | 19.11M | 22.35M | 15.89M |
| StockBasedCompensation | 34.79M | 25.51M | 20.52M | 21.41M |
| DeferredTax | 80.77M | -26.63M | -25.12M | -23.01M |
| DeferredIncomeTax | 80.77M | -26.63M | -25.12M | -23.01M |
| DepreciationAmortizationDepletion | 28.12M | 29.25M | 26.33M | 22.34M |
| DepreciationAndAmortization | 28.12M | 29.25M | 26.33M | 22.34M |
| AmortizationCashFlow | 946.00K | 1.44M | 2.20M | 3.35M |
| AmortizationOfIntangibles | 946.00K | 1.44M | 2.20M | 3.35M |
| Depreciation | 27.18M | 27.81M | 24.13M | 18.99M |
| NetIncomeFromContinuingOperations | 451.12M | 404.39M | 282.81M | 245.37M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for MEDP
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|